关于发现GLP-1作为腹激素的反思:对肥胖疗法的影响和未来的方向
1Department of Obesity and Nutritional Sciences, Novo Nordisk Foundation, Hellerup, Denmark. ara@novo.dk.
European journal of clinical nutrition
|June 18, 2024
概括
葡萄糖类-1 (GLP-1) 的发现揭示了它在和胃空化的作用. GLP-1类似物现在是对肥胖,2型糖尿病和心血管事件的有效治疗方法.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 胰岛素激素调节葡萄糖代谢和食欲.
- 类似葡萄糖-1 (GLP-1) 是一种关键的内激素.
- 了解GLP-1的生理影响对于代谢疾病治疗至关重要.
研究的目的:
- 阐明GLP-1的生理机制.
- 突出GLP-1类似物在肥胖和相关疾病中的治疗潜力.
主要方法:
- 发现和描述GLP-1激素.
- 分析GLP-1对腹感,胃空和胰岛素反应的影响.
主要成果:
- GLP-1表现出显著的和效应.
- GLP-1减缓了胃空化的速度.
- GLP-1可以降低食后胰岛素反应.
结论:
- GLP-1的机制支持GLP-1类似物在治疗肥胖症方面的疗效.
- GLP-1类似物有助于2型糖尿病的缓解和减少心血管事件.
- 基于GLP-1的疗法为代谢和心血管健康提供了一个有希望的方法.
相关概念视频
Glucagon-like Receptor Agonists
316
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
316
Regulation of Food Intake
218
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
218
Hormonal Regulation
43.4K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.4K
Dipeptidyl Peptidase 4 Inhibitors
181
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
181
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
Obesity
451
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
451


